DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Alsuma is a drug marketed by Meridian Medcl and is included in one NDA. There is one patent protecting this drug.
This drug has four patent family members in four countries.
The generic ingredient in ALSUMA is sumatriptan succinate. There are twenty-four drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the sumatriptan succinate profile page.
A generic version of ALSUMA was approved as sumatriptan succinate by WEST-WARD PHARMS INT on February 6th, 2009.
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Meridian Medcl||ALSUMA||sumatriptan succinate||INJECTABLE;SUBCUTANEOUS||022377-001||Jun 29, 2010||DISCN||No||No||Start Trial||Start Trial||Y||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
|Country||Patent Number||Estimated Expiration|
|World Intellectual Property Organization (WIPO)||2008048750||Start Trial|
|European Patent Office||2073866||Start Trial|
|>Country||>Patent Number||>Estimated Expiration|